05:38 PM EDT, 03/24/2026 (MT Newswires) -- Medtronic ( MDT ) cut its fiscal 2026 non-GAAP earnings guidance to $5.50 to $5.54 a share from $5.62 to $5.66 projected in mid-February.

The company said Tuesday in a regulatory filing that the revision reflects a one-time $157 million charge tied to the early US Food and Drug Administration clearance of MiniMed Flex, which will reduce fiscal Q4 EPS by $0.08, and dilution of $0.04 from the initial public offering of a 10% stake in MiniMed.